ヒト B 型肝炎免疫グロブリン（HBIG）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Human Hepatitis B Immunoglobulin(HBIG) Market Insights and Forecast to 2028

• レポートコード：QY2203B05192 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のヒト B 型肝炎免疫グロブリン（HBIG）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒト B 型肝炎免疫グロブリン（HBIG）の世界市場のxxx％を占める「100IU/ボトル ヒト B 型肝炎免疫グロブリン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「B型肝炎表面抗原(HBsAg)を持つ母親から生まれた陽性児」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のヒト B 型肝炎免疫グロブリン（HBIG）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのヒト B 型肝炎免疫グロブリン（HBIG）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのヒト B 型肝炎免疫グロブリン（HBIG）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ヒト B 型肝炎免疫グロブリン（HBIG）のグローバル主要メーカーには、Baxter、CSL、Bayer、Grifols、Octapharma、Shanghai RAAS、Hualan Biological、China Biologic、Tiantan Biologic、Shuanglin Bio-pharmacy、Sichuan Yuanda Shuyang、Boya Bio-pharmaceutical、Shanghai Institute of Biologicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ヒト B 型肝炎免疫グロブリン（HBIG）市場は、種類と用途によって区分されます。世界のヒト B 型肝炎免疫グロブリン（HBIG）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 100IU/ボトル ヒト B 型肝炎免疫グロブリン、200IU/ボトル ヒト B 型肝炎免疫グロブリン、400IU/ボトル ヒト B 型肝炎免疫グロブリン 【用途別セグメント】 B型肝炎表面抗原(HBsAg)を持つ母親から生まれた陽性児、予期せぬB型肝炎の群衆、B型肝炎患者及びB型肝炎ウイルスキャリアの密接な接触者。 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ヒト B 型肝炎免疫グロブリン（HBIG）製品概要 - 種類別市場（100IU/ボトル ヒト B 型肝炎免疫グロブリン、200IU/ボトル ヒト B 型肝炎免疫グロブリン、400IU/ボトル ヒト B 型肝炎免疫グロブリン） - 用途別市場（B型肝炎表面抗原(HBsAg)を持つ母親から生まれた陽性児、予期せぬB型肝炎の群衆、B型肝炎患者及びB型肝炎ウイルスキャリアの密接な接触者。） - 調査の目的 ・エグゼクティブサマリー - 世界のヒト B 型肝炎免疫グロブリン（HBIG）販売量予測2017-2028 - 世界のヒト B 型肝炎免疫グロブリン（HBIG）売上予測2017-2028 - ヒト B 型肝炎免疫グロブリン（HBIG）の地域別販売量 - ヒト B 型肝炎免疫グロブリン（HBIG）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ヒト B 型肝炎免疫グロブリン（HBIG）販売量 - 主要メーカー別ヒト B 型肝炎免疫グロブリン（HBIG）売上 - 主要メーカー別ヒト B 型肝炎免疫グロブリン（HBIG）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（100IU/ボトル ヒト B 型肝炎免疫グロブリン、200IU/ボトル ヒト B 型肝炎免疫グロブリン、400IU/ボトル ヒト B 型肝炎免疫グロブリン） - ヒト B 型肝炎免疫グロブリン（HBIG）の種類別販売量 - ヒト B 型肝炎免疫グロブリン（HBIG）の種類別売上 - ヒト B 型肝炎免疫グロブリン（HBIG）の種類別価格 ・用途別市場規模（B型肝炎表面抗原(HBsAg)を持つ母親から生まれた陽性児、予期せぬB型肝炎の群衆、B型肝炎患者及びB型肝炎ウイルスキャリアの密接な接触者。） - ヒト B 型肝炎免疫グロブリン（HBIG）の用途別販売量 - ヒト B 型肝炎免疫グロブリン（HBIG）の用途別売上 - ヒト B 型肝炎免疫グロブリン（HBIG）の用途別価格 ・北米市場 - 北米のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（種類別、用途別） - 主要国別のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのヒト B 型肝炎免疫グロブリン（HBIG）市場規模（種類別、用途別） - 主要国別のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（種類別、用途別） - 主要国別のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（種類別、用途別） - 主要国別のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのヒト B 型肝炎免疫グロブリン（HBIG）市場規模（種類別、用途別） - 主要国別のヒト B 型肝炎免疫グロブリン（HBIG）市場規模（トルコ、サウジアラビア） ・企業情報 Baxter、CSL、Bayer、Grifols、Octapharma、Shanghai RAAS、Hualan Biological、China Biologic、Tiantan Biologic、Shuanglin Bio-pharmacy、Sichuan Yuanda Shuyang、Boya Bio-pharmaceutical、Shanghai Institute of Biological ・産業チェーン及び販売チャネル分析 - ヒト B 型肝炎免疫グロブリン（HBIG）の産業チェーン分析 - ヒト B 型肝炎免疫グロブリン（HBIG）の原材料 - ヒト B 型肝炎免疫グロブリン（HBIG）の生産プロセス - ヒト B 型肝炎免疫グロブリン（HBIG）の販売及びマーケティング - ヒト B 型肝炎免疫グロブリン（HBIG）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ヒト B 型肝炎免疫グロブリン（HBIG）の産業動向 - ヒト B 型肝炎免疫グロブリン（HBIG）のマーケットドライバー - ヒト B 型肝炎免疫グロブリン（HBIG）の課題 - ヒト B 型肝炎免疫グロブリン（HBIG）の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Human Hepatitis B Immunoglobulin(HBIG) Market
Due to the COVID-19 pandemic, the global Human Hepatitis B Immunoglobulin(HBIG) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 100IU/Bottle Human Hepatitis B Immunoglobulin accounting for % of the Human Hepatitis B Immunoglobulin(HBIG) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg) segment is altered to an % CAGR throughout this forecast period.
China Human Hepatitis B Immunoglobulin(HBIG) market size is valued at US$ million in 2021, while the US and Europe Human Hepatitis B Immunoglobulin(HBIG) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Human Hepatitis B Immunoglobulin(HBIG) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Human Hepatitis B Immunoglobulin(HBIG) include Baxter, CSL, Bayer, Grifols, Octapharma, Shanghai RAAS, Hualan Biological, China Biologic and Tiantan Biologic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Human Hepatitis B Immunoglobulin(HBIG) Scope and Segment
Human Hepatitis B Immunoglobulin(HBIG) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Hepatitis B Immunoglobulin(HBIG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100IU/Bottle Human Hepatitis B Immunoglobulin
200IU/Bottle Human Hepatitis B Immunoglobulin
400IU/Bottle Human Hepatitis B Immunoglobulin
Segment by Application
Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Unexpected Crowd of Hepatitis B Infection
Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
By Company
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Human Hepatitis B Immunoglobulin(HBIG) Product Introduction
1.2 Market by Type
1.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin
1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin
1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin
1.3 Market by Application
1.3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
1.3.3 Unexpected Crowd of Hepatitis B Infection
1.3.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales Estimates and Forecasts 2017-2028
2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Region
2.4.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2017-2022)
2.4.2 Global Sales Human Hepatitis B Immunoglobulin(HBIG) by Region (2023-2028)
2.5 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region
2.5.1 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2017-2022)
2.5.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Manufacturers
3.1.1 Global Top Human Hepatitis B Immunoglobulin(HBIG) Manufacturers by Sales (2017-2022)
3.1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Hepatitis B Immunoglobulin(HBIG) in 2021
3.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Manufacturers
3.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Hepatitis B Immunoglobulin(HBIG) Revenue in 2021
3.3 Global Human Hepatitis B Immunoglobulin(HBIG) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Hepatitis B Immunoglobulin(HBIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Hepatitis B Immunoglobulin(HBIG) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Type
4.1.1 Global Human Hepatitis B Immunoglobulin(HBIG) Historical Sales by Type (2017-2022)
4.1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2028)
4.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type
4.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Historical Revenue by Type (2017-2022)
4.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2028)
4.3 Global Human Hepatitis B Immunoglobulin(HBIG) Price by Type
4.3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Price by Type (2017-2022)
4.3.2 Global Human Hepatitis B Immunoglobulin(HBIG) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Application
5.1.1 Global Human Hepatitis B Immunoglobulin(HBIG) Historical Sales by Application (2017-2022)
5.1.2 Global Human Hepatitis B Immunoglobulin(HBIG) Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2028)
5.2 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application
5.2.1 Global Human Hepatitis B Immunoglobulin(HBIG) Historical Revenue by Application (2017-2022)
5.2.2 Global Human Hepatitis B Immunoglobulin(HBIG) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2028)
5.3 Global Human Hepatitis B Immunoglobulin(HBIG) Price by Application
5.3.1 Global Human Hepatitis B Immunoglobulin(HBIG) Price by Application (2017-2022)
5.3.2 Global Human Hepatitis B Immunoglobulin(HBIG) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Hepatitis B Immunoglobulin(HBIG) Market Size by Type
6.1.1 North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2028)
6.1.2 North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2028)
6.2 North America Human Hepatitis B Immunoglobulin(HBIG) Market Size by Application
6.2.1 North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2028)
6.2.2 North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2028)
6.3 North America Human Hepatitis B Immunoglobulin(HBIG) Market Size by Country
6.3.1 North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2028)
6.3.2 North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Hepatitis B Immunoglobulin(HBIG) Market Size by Type
7.1.1 Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2028)
7.1.2 Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2028)
7.2 Europe Human Hepatitis B Immunoglobulin(HBIG) Market Size by Application
7.2.1 Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2028)
7.2.2 Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2028)
7.3 Europe Human Hepatitis B Immunoglobulin(HBIG) Market Size by Country
7.3.1 Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2028)
7.3.2 Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Market Size by Type
8.1.1 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2028)
8.2 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Market Size by Application
8.2.1 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2028)
8.3 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Market Size by Region
8.3.1 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Hepatitis B Immunoglobulin(HBIG) Market Size by Type
9.1.1 Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2028)
9.1.2 Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2028)
9.2 Latin America Human Hepatitis B Immunoglobulin(HBIG) Market Size by Application
9.2.1 Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2028)
9.2.2 Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2028)
9.3 Latin America Human Hepatitis B Immunoglobulin(HBIG) Market Size by Country
9.3.1 Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2028)
9.3.2 Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Market Size by Type
10.1.1 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Market Size by Application
10.2.1 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Market Size by Country
10.3.1 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Grifols
11.4.1 Grifols Corporation Information
11.4.2 Grifols Overview
11.4.3 Grifols Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Grifols Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Grifols Recent Developments
11.5 Octapharma
11.5.1 Octapharma Corporation Information
11.5.2 Octapharma Overview
11.5.3 Octapharma Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Octapharma Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Octapharma Recent Developments
11.6 Shanghai RAAS
11.6.1 Shanghai RAAS Corporation Information
11.6.2 Shanghai RAAS Overview
11.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanghai RAAS Recent Developments
11.7 Hualan Biological
11.7.1 Hualan Biological Corporation Information
11.7.2 Hualan Biological Overview
11.7.3 Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Biological Recent Developments
11.8 China Biologic
11.8.1 China Biologic Corporation Information
11.8.2 China Biologic Overview
11.8.3 China Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 China Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 China Biologic Recent Developments
11.9 Tiantan Biologic
11.9.1 Tiantan Biologic Corporation Information
11.9.2 Tiantan Biologic Overview
11.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tiantan Biologic Recent Developments
11.10 Shuanglin Bio-pharmacy
11.10.1 Shuanglin Bio-pharmacy Corporation Information
11.10.2 Shuanglin Bio-pharmacy Overview
11.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shuanglin Bio-pharmacy Recent Developments
11.11 Sichuan Yuanda Shuyang
11.11.1 Sichuan Yuanda Shuyang Corporation Information
11.11.2 Sichuan Yuanda Shuyang Overview
11.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sichuan Yuanda Shuyang Recent Developments
11.12 Boya Bio-pharmaceutical
11.12.1 Boya Bio-pharmaceutical Corporation Information
11.12.2 Boya Bio-pharmaceutical Overview
11.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Boya Bio-pharmaceutical Recent Developments
11.13 Shanghai Institute of Biological
11.13.1 Shanghai Institute of Biological Corporation Information
11.13.2 Shanghai Institute of Biological Overview
11.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai Institute of Biological Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Hepatitis B Immunoglobulin(HBIG) Industry Chain Analysis
12.2 Human Hepatitis B Immunoglobulin(HBIG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Hepatitis B Immunoglobulin(HBIG) Production Mode & Process
12.4 Human Hepatitis B Immunoglobulin(HBIG) Sales and Marketing
12.4.1 Human Hepatitis B Immunoglobulin(HBIG) Sales Channels
12.4.2 Human Hepatitis B Immunoglobulin(HBIG) Distributors
12.5 Human Hepatitis B Immunoglobulin(HBIG) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Hepatitis B Immunoglobulin(HBIG) Industry Trends
13.2 Human Hepatitis B Immunoglobulin(HBIG) Market Drivers
13.3 Human Hepatitis B Immunoglobulin(HBIG) Market Challenges
13.4 Human Hepatitis B Immunoglobulin(HBIG) Market Restraints
14 Key Findings in The Global Human Hepatitis B Immunoglobulin(HBIG) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Human Hepatitis B Immunoglobulin(HBIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100IU/Bottle Human Hepatitis B Immunoglobulin
Table 3. Major Manufacturers of 200IU/Bottle Human Hepatitis B Immunoglobulin
Table 4. Major Manufacturers of 400IU/Bottle Human Hepatitis B Immunoglobulin
Table 5. Global Human Hepatitis B Immunoglobulin(HBIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2017-2022) & (K Pcs)
Table 8. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Region (2017-2022)
Table 9. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2023-2028) & (K Pcs)
Table 10. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Region (2023-2028)
Table 11. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Region (2017-2022)
Table 13. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Region (2023-2028)
Table 15. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Manufacturers (2017-2022) & (K Pcs)
Table 16. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Manufacturers (2017-2022)
Table 17. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Manufacturers (2017-2022)
Table 19. Human Hepatitis B Immunoglobulin(HBIG) Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 20. Global Human Hepatitis B Immunoglobulin(HBIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Human Hepatitis B Immunoglobulin(HBIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hepatitis B Immunoglobulin(HBIG) as of 2021)
Table 22. Human Hepatitis B Immunoglobulin(HBIG) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Human Hepatitis B Immunoglobulin(HBIG) Product Offered
Table 24. Date of Manufacturers Enter into Human Hepatitis B Immunoglobulin(HBIG) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 27. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2023-2028) & (K Pcs)
Table 28. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Type (2017-2022)
Table 29. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Type (2023-2028)
Table 30. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Type (2017-2022)
Table 33. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Type (2023-2028)
Table 34. Human Hepatitis B Immunoglobulin(HBIG) Price by Type (2017-2022) & (USD/Pcs)
Table 35. Global Human Hepatitis B Immunoglobulin(HBIG) Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 36. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 37. Global Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2023-2028) & (K Pcs)
Table 38. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Application (2017-2022)
Table 39. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Application (2023-2028)
Table 40. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Application (2017-2022)
Table 43. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Application (2023-2028)
Table 44. Human Hepatitis B Immunoglobulin(HBIG) Price by Application (2017-2022) & (USD/Pcs)
Table 45. Global Human Hepatitis B Immunoglobulin(HBIG) Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 46. North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 47. North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2023-2028) & (K Pcs)
Table 48. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 51. North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2023-2028) & (K Pcs)
Table 52. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022) & (K Pcs)
Table 55. North America Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2023-2028) & (K Pcs)
Table 56. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2023-2028) & (K Pcs)
Table 60. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 63. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2023-2028) & (K Pcs)
Table 64. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022) & (K Pcs)
Table 67. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2023-2028) & (K Pcs)
Table 68. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 71. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2023-2028) & (K Pcs)
Table 72. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 75. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2023-2028) & (K Pcs)
Table 76. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2017-2022) & (K Pcs)
Table 79. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales by Region (2023-2028) & (K Pcs)
Table 80. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 83. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2023-2028) & (K Pcs)
Table 84. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 87. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2023-2028) & (K Pcs)
Table 88. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022) & (K Pcs)
Table 91. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2023-2028) & (K Pcs)
Table 92. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2017-2022) & (K Pcs)
Table 95. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Type (2023-2028) & (K Pcs)
Table 96. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2017-2022) & (K Pcs)
Table 99. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Application (2023-2028) & (K Pcs)
Table 100. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2017-2022) & (K Pcs)
Table 103. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales by Country (2023-2028) & (K Pcs)
Table 104. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue by Country (2023-2028) & (US$ Million)
Table 106. Baxter Corporation Information
Table 107. Baxter Description and Major Businesses
Table 108. Baxter Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 109. Baxter Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Baxter Recent Developments
Table 111. CSL Corporation Information
Table 112. CSL Description and Major Businesses
Table 113. CSL Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 114. CSL Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. CSL Recent Developments
Table 116. Bayer Corporation Information
Table 117. Bayer Description and Major Businesses
Table 118. Bayer Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 119. Bayer Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Bayer Recent Developments
Table 121. Grifols Corporation Information
Table 122. Grifols Description and Major Businesses
Table 123. Grifols Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 124. Grifols Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Grifols Recent Developments
Table 126. Octapharma Corporation Information
Table 127. Octapharma Description and Major Businesses
Table 128. Octapharma Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 129. Octapharma Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Octapharma Recent Developments
Table 131. Shanghai RAAS Corporation Information
Table 132. Shanghai RAAS Description and Major Businesses
Table 133. Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 134. Shanghai RAAS Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Shanghai RAAS Recent Developments
Table 136. Hualan Biological Corporation Information
Table 137. Hualan Biological Description and Major Businesses
Table 138. Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 139. Hualan Biological Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Hualan Biological Recent Developments
Table 141. China Biologic Corporation Information
Table 142. China Biologic Description and Major Businesses
Table 143. China Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 144. China Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. China Biologic Recent Developments
Table 146. Tiantan Biologic Corporation Information
Table 147. Tiantan Biologic Description and Major Businesses
Table 148. Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 149. Tiantan Biologic Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Tiantan Biologic Recent Developments
Table 151. Shuanglin Bio-pharmacy Corporation Information
Table 152. Shuanglin Bio-pharmacy Description and Major Businesses
Table 153. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 154. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Shuanglin Bio-pharmacy Recent Developments
Table 156. Sichuan Yuanda Shuyang Corporation Information
Table 157. Sichuan Yuanda Shuyang Description and Major Businesses
Table 158. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 159. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Sichuan Yuanda Shuyang Recent Developments
Table 161. Boya Bio-pharmaceutical Corporation Information
Table 162. Boya Bio-pharmaceutical Description and Major Businesses
Table 163. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 164. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Boya Bio-pharmaceutical Recent Developments
Table 166. Shanghai Institute of Biological Corporation Information
Table 167. Shanghai Institute of Biological Description and Major Businesses
Table 168. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 169. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin(HBIG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Shanghai Institute of Biological Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Human Hepatitis B Immunoglobulin(HBIG) Distributors List
Table 174. Human Hepatitis B Immunoglobulin(HBIG) Customers List
Table 175. Human Hepatitis B Immunoglobulin(HBIG) Market Trends
Table 176. Human Hepatitis B Immunoglobulin(HBIG) Market Drivers
Table 177. Human Hepatitis B Immunoglobulin(HBIG) Market Challenges
Table 178. Human Hepatitis B Immunoglobulin(HBIG) Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin(HBIG) Product Picture
Figure 3. Global Human Hepatitis B Immunoglobulin(HBIG) Market Share by Type in 2021 & 2028
Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin Product Picture
Figure 6. Global Human Hepatitis B Immunoglobulin(HBIG) Market Share by Application in 2021 & 2028
Figure 7. Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
Figure 8. Unexpected Crowd of Hepatitis B Infection
Figure 9. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
Figure 10. Human Hepatitis B Immunoglobulin(HBIG) Report Years Considered
Figure 11. Global Human Hepatitis B Immunoglobulin(HBIG) Sales 2017-2028 (K Pcs)
Figure 12. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue 2017-2028 (US$ Million)
Figure 14. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Region (2017-2022)
Figure 16. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Region (2023-2028)
Figure 17. North America Human Hepatitis B Immunoglobulin(HBIG) Sales YoY (2017-2028) & (K Pcs)
Figure 18. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales YoY (2017-2028) & (K Pcs)
Figure 20. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales YoY (2017-2028) & (K Pcs)
Figure 22. Asia-Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales YoY (2017-2028) & (K Pcs)
Figure 24. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Sales YoY (2017-2028) & (K Pcs)
Figure 26. Middle East & Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Human Hepatitis B Immunoglobulin(HBIG) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Hepatitis B Immunoglobulin(HBIG) in the World: Market Share by Human Hepatitis B Immunoglobulin(HBIG) Revenue in 2021
Figure 29. Global Human Hepatitis B Immunoglobulin(HBIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2028)
Figure 31. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2028)
Figure 32. Global Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2028)
Figure 33. Global Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2028)
Figure 34. North America Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2028)
Figure 35. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2028)
Figure 36. North America Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2028)
Figure 37. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2028)
Figure 38. North America Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Country (2017-2028)
Figure 39. North America Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Country (2017-2028)
Figure 40. U.S. Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2028)
Figure 43. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2028)
Figure 44. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2028)
Figure 46. Europe Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Country (2017-2028)
Figure 47. Europe Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Country (2017-2028)
Figure 48. Germany Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 49. France Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Region (2017-2028)
Figure 59. China Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 62. India Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2028)
Figure 70. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2028)
Figure 72. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Country (2017-2028)
Figure 74. Latin America Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Country (2017-2028)
Figure 75. Mexico Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Human Hepatitis B Immunoglobulin(HBIG) Revenue Share by Country (2017-2028)
Figure 84. Turkey Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Human Hepatitis B Immunoglobulin(HBIG) Revenue (2017-2028) & (US$ Million)
Figure 87. Human Hepatitis B Immunoglobulin(HBIG) Value Chain
Figure 88. Human Hepatitis B Immunoglobulin(HBIG) Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---